Dr Emily Walkom

Dr Emily Walkom

Research Officer/Evaluator

School of Medicine and Public Health (Clinical Pharmacology and Clinical Toxicology)

Career Summary


I completed my PhD in psychology at the University of Newcastle in 2002. My PhD examined the relationship between children's computer game playing and their social behaviour. Since starting with the discipline of Clinical Pharmacology in June 2002, I have been involved in a number of research projects around medicines use, including systematic reviews, surveys of medical practitioners and the general public, and qualitative research. In my current role as a research academic my key focus is providing external evaluations of submissions to the Pharmaceutical Benefits Advisory Committee. My research interests include medicines affordability, quality use of medicines and medicines policy. 


  • PhD, University of Newcastle
  • Bachelor of Arts (Psychology) Honours, University of Newcastle


  • Health Care Systems
  • Medicines

Fields of Research

Code Description Percentage
119999 Medical and Health Sciences not elsewhere classified 70
160599 Policy and Administration not elsewhere classified 15
111799 Public Health and Health Services not elsewhere classified 15

Professional Experience

UON Appointment

Title Organisation / Department
Research Officer/Evaluator University of Newcastle
School of Medicine and Public Health
Research Officer/Evaluator Priority Research Centre (PRC) for Healthy Lungs | The University of Newcastle
School of Medicine and Public Health
Research Officer/Evaluator University of Newcastle
School of Medicine and Public Health

Academic appointment

Dates Title Organisation / Department
1/01/2014 -  Membership - ISPOR Australia Chapter ISPOR Australia Chapter


For publications that are currently unpublished or in-press, details are shown in italics.

Journal article (18 outputs)

Year Citation Altmetrics Link
2019 Bevan M, Ng YC, Cooper J, Robertson J, Walkom E, Chiu S, Newby DA, 'The role of evidence in consumer choice of non-prescription medicines', International Journal of Pharmacy Practice, 27 501-509 (2019) [C1]

© 2019 Royal Pharmaceutical Society Objectives: To identify factors influencing Australian consumer decision-making and attitudes towards non-prescription medicine (NPM) purchases... [more]

© 2019 Royal Pharmaceutical Society Objectives: To identify factors influencing Australian consumer decision-making and attitudes towards non-prescription medicine (NPM) purchases, pharmacy's role in providing these medications and views around sources of evidence for effectiveness of these products. Methods: Cross-sectional survey of a general population sample of 1731 adults using an Australian online consumer panel stratified by gender, age and location (State/Territory). Beliefs about NPM purchases and evidence of their efficacy were assessed using a 5-point Likert scale (strongly disagree-strongly agree). Non-parametric measures (Ridit analysis and Mann¿Whitney U-test) were used to explore associations between responses and previous experience with medicines. Key findings: The most important factors when purchasing NPMs were effectiveness and safety. However, personal experience was the most common method of determining effectiveness. Most respondents believed buying NPMs in pharmacies gave access to advice, but were less likely to agree that pharmacies were associated with safe and effective treatments. Around half the respondents agreed that it is wrong to sell treatments lacking scientific evidence; many also agreed that it is up to consumers to decide what they want even without scientific evidence. Individuals experiencing an ineffective NPM were less likely to trust scientific evidence of efficacy as the sole source of effectiveness information; regular prescription medicine users often agreed that scientific evidence is needed to support effectiveness. Conclusions: Consumers have conflicting views regarding the need for scientific evidence and the desire for patient autonomy in NPM purchases. This presents a challenge for pharmacists wishing to maintain professional obligations to provide evidence-based treatments to consumers.

DOI 10.1111/ijpp.12546
Co-authors David Newby, Joyce Cooper
2017 Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA, 'A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia', BMJ Open, 7 (2017) [C1]
DOI 10.1136/bmjopen-2017-016701
Citations Scopus - 10Web of Science - 11
2016 Athuraliya N, Walkom EJ, Dharmaratne S, Robertson J, 'Assessing medication packaging and labelling appropriateness in Sri Lanka.', J Pharm Policy Pract, 9 38 (2016) [C1]
DOI 10.1186/s40545-016-0091-5
Citations Scopus - 3
2016 Robertson J, Newby DA, Walkom EJ, 'Health Care Spending: Changes in the Perceptions of the Australian Public.', PloS one, 11 e0157312 (2016) [C1]
DOI 10.1371/journal.pone.0157312
Citations Scopus - 2Web of Science - 2
Co-authors David Newby
2015 Ren S, Newby D, Li SC, Walkom E, Miller P, Hure A, Attia J, 'Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis.', Open Heart, 2 1-9 (2015) [C1]
DOI 10.1136/openhrt-2015-000247
Citations Web of Science - 27
Co-authors John Attia, Alexis Hure, David Newby, Shuchuen Li
2013 Loxton D, Robertson J, Walkom EJ, 'Costs of medicines and health care: a concern for Australian women across the ages.', BMC Health Services Research, 13 (2013) [C1]
DOI 10.1186/1472-6963-13-484
Citations Scopus - 9Web of Science - 8
Co-authors Deborah Loxton
2013 Robertson J, Walkom EJ, Bevan MD, Newby DA, 'Medicines and the media: news reports of medicines recommended for government reimbursement in Australia', BMC PUBLIC HEALTH, 13 (2013) [C1]
DOI 10.1186/1471-2458-13-489
Citations Scopus - 8Web of Science - 9
Co-authors David Newby
2011 Robertson J, Walkom EJ, Henry DA, 'Health systems and sustainability: Doctors and consumers differ on threats and solutions', PLoS ONE, 6 (2011) [C1]
DOI 10.1371/journal.pone.0019222
Citations Scopus - 8Web of Science - 9
2010 Robertson J, Walkom EJ, Pearson S-A, Hains I, Williamson M, Newby DA, 'The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: A systematic review of the literature', International Journal of Pharmacy Practice, 18 69-87 (2010) [C1]
DOI 10.1211/ijpp/18.02.0002
Citations Scopus - 38
Co-authors David Newby
2010 Robertson J, Walkom EJ, Moynihan R, Bero L, Henry DA, 'Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme', International Journal of Pharmacy Practice, 18 88-92 (2010) [C1]
DOI 10.1211/ijpp/18.02.0003
Citations Scopus - 1
Co-authors Mddah01
2009 Robertson J, Moynihan R, Walkom EJ, Bero L, Henry DA, 'Mandatory disclosure of pharmaceutical industry-funded events for health professionals', PLoS Medicine, 6 e1000128 (2009) [C1]
DOI 10.1371/journal.pmed.1000128
Citations Scopus - 20Web of Science - 18
Co-authors Mddah01
2009 Robertson J, Walkom EJ, Henry DA, 'Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme', Australian Health Review, 33 192-199 (2009) [C1]
DOI 10.1071/AH090192
Citations Scopus - 16Web of Science - 10
2008 Harris AH, Hill SR, Chin G, Jing Jing L, Walkom EJ, 'The role of value for money in public insurance coverage decisions for drugs in australia: A retrospective analysis 1994-2004', Medical Decision Making, 28 713-722 (2008) [C1]
DOI 10.1177/0272989x08315247
Citations Scopus - 139Web of Science - 126
2006 Walkom EJ, Robertson J, Newby DA, Pillay T, 'The role of pharmacoeconomics in formulary decision-making - Considerations for hospital and managed care pharmacy and therapeutics committees', Formulary, 41 374-385 (2006) [C1]
DOI 10.1016/j.jsps.2010.10.005
Citations Scopus - 13Web of Science - 9
Co-authors David Newby
2005 Robertson J, Walkom EJ, McGettigan P, 'Response rates and representativeness: a lottery incentive improves physician survey return rates', Pharmacoepidemiology and Drug Safety, 14 571-577 (2005) [C1]
DOI 10.1002/pds.1126
Citations Scopus - 47Web of Science - 47
2005 Smith A, Hill S, Walkom E, Thambiran M, 'An evaluation of the World Health Organization problem-based pharmacotherapy teaching courses (based on the "Guide to Good Prescribing"), 1994-2001', EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 61 785-786 (2005)
DOI 10.1007/s00228-005-0990-x
Citations Scopus - 3Web of Science - 1
Co-authors Anthony Smith
2001 Carr SC, Rugimbana RO, Walkom E, Bolitho FH, 'Selecting expatriates in developing areas: "country-of-origin" effects in Tanzania?', INTERNATIONAL JOURNAL OF INTERCULTURAL RELATIONS, 25 441-457 (2001)
DOI 10.1016/S0147-1767(01)00015-3
Citations Scopus - 27Web of Science - 25
2000 Rugimbana RO, Carr S, Bolitho F, Walkom E, 'The Impact of "Consumer Cringe" on Developing Regional Trade Blocks:A Tanzanian Case Study', Journal of African Business, 1,2 91-106 (2000) [C1]
Citations Scopus - 1
Show 15 more journal articles

Conference (2 outputs)

Year Citation Altmetrics Link
2010 Robertson J, Bevan MD, Walkom EJ, Newby DA, 'News Reports of Medicines in Relation to Decisions of the Australian Pharmaceutical Benefits Advisory Committee', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Co-authors David Newby
2010 Robertson J, Bevan M, Walkom EJ, Newby DA, 'News reports of medicines in relation to decisions of the Australian Pharmaceutical Benefits Advisory Committee (PBAC)', National Medicines Symposium 2010. Abstracts, Melbourne, Vic (2010) [E3]
Co-authors David Newby

Thesis / Dissertation (1 outputs)

Year Citation Altmetrics Link
2002 Walkom EJ, Relationships between computer game play and children's social behaviour., University of Newcastle (2002)

Grants and Funding


Number of grants 1
Total funding $5,810,624

Click on a grant title below to expand the full details for that specific grant.

20161 grants / $5,810,624

Provision of external evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and health technology related submissions$5,810,624

Funding body: Department of Health

Funding body Department of Health
Project Team Ms Danielle Lang, Mr Rob Bell, Mr Marc Bevan, Ms Lynn Goon, Doctor Madeleine Hinwood, Mr Jarrod Bell, Doctor Emily Walkom
Scheme Consultancy/Tender
Role Investigator
Funding Start 2016
Funding Finish 2020
GNo G1601071
Type Of Funding C2110 - Aust Commonwealth - Own Purpose
Category 2110

Dr Emily Walkom


Research Officer/Evaluator
Newcastle Evaluation Group
School of Medicine and Public Health
Faculty of Health and Medicine

Focus area

Clinical Pharmacology and Clinical Toxicology

Contact Details

Email emily.walkom@newcastle.edu.au
Phone (02) 4014 3009
Fax (02) 4960 2088


Room NM2-545
Building Mater Hospital Level 5 - New Med 2
Location Mater Hospital